KEY
33
3
RHI
44
4
CI
38
5
HOG
29
2
GME
65
3
DRI
69
5
CF
56
6
VMC
33
3
ORLY
43
4
MSFT
46
3
OI
32
-2
CMG
51
-3
SRE
49
4
ECL
44
4
FAST
30
2
KMI
83
2
XEL
50
-3
MTB
44
3
QCOM
52
4
EL
24
-3
KEY
33
3
RHI
44
4
CI
38
5
HOG
29
2
GME
65
3
DRI
69
5
CF
56
6
VMC
33
3
ORLY
43
4
MSFT
46
3
OI
32
-2
CMG
51
-3
SRE
49
4
ECL
44
4
FAST
30
2
KMI
83
2
XEL
50
-3
MTB
44
3
QCOM
52
4
EL
24
-3
Financhill
Back

CrossingBridge Pre-Merger SPAC ETF Vs. Aligos Therapeutics Industry Stock Comparison

Sell
10

SPC
CrossingBridge Pre-Merger SPAC ETF

Last Price:
$20.65
Seasonality Move:
0.97%
Buy
69

ALGS
Aligos Therapeutics

Last Price:
$43.44
Seasonality Move:
-17.17%
Sell
10
CrossingBridge Pre-Merger SPAC ETF (SPC) is a Sell

Is CrossingBridge Pre-Merger SPAC ETF a Buy, Sell or Hold?

  • The current CrossingBridge Pre-Merger SPAC ETF [SPC] share price is $20.69. The Score for SPC is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • SPC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
69
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $43.42. The Score for ALGS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SPC Stock Price Chart

What is CrossingBridge Pre-Merger SPAC ETF's stock price today?

  • The CrossingBridge Pre-Merger SPAC ETF share price today is $20.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPC is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $43.42
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

SPC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 17.48 Sell
Chaikin Money Flow: 3578 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.03 - 21.93) Sell
Bollinger Bands (100): (21.37 - 21.89) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.14 Buy
Relative Strength Index (14 RSI): 74.33 Buy
Chaikin Money Flow: 210748 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.82 - 40.1) Buy
Bollinger Bands (100): (6.77 - 28.07) Buy

SPC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.94 Sell
20-day SMA: 21.43 Sell
50-day SMA: 21.56 Sell
200-day SMA: 21.61 Sell
8-day EMA: 20.91 Sell
20-day EMA: 21.25 Sell
50-day EMA: 21.48 Sell
200-day EMA: 21.58 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.78 Buy
20-day SMA: 36.11 Buy
50-day SMA: 23.97 Buy
200-day SMA: 16.97 Buy
8-day EMA: 40.32 Buy
20-day EMA: 35.95 Buy
50-day EMA: 27.43 Buy
200-day EMA: 19.22 Buy

CrossingBridge Pre-Merger SPAC ETF Earnings Growth & SPC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.

CrossingBridge Pre-Merger SPAC ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):